Global Acute Intermittent Porphyria Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI320958
- March 20, 2019
- Global
- 94 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Acute Intermittent Porphyria market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Acute Intermittent Porphyria market."
Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.
The global Acute Intermittent Porphyria market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Acute Intermittent Porphyria volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Intermittent Porphyria market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions
Segment by Application
Hospitals & Clinics
Research Centers
Table of Contents
Executive Summary
1 Acute Intermittent Porphyria Market Overview
1.1 Product Overview and Scope of Acute Intermittent Porphyria
1.2 Acute Intermittent Porphyria Segment by Type
1.2.1 Global Acute Intermittent Porphyria Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Gonadotropin-Releasing Hormone Analogues
1.2.3 Prophylactic Hematin Infusions
1.3 Acute Intermittent Porphyria Segment by Application
1.3.1 Acute Intermittent Porphyria Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Global Acute Intermittent Porphyria Market by Region
1.4.1 Global Acute Intermittent Porphyria Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Acute Intermittent Porphyria Market Size
1.5.1 Global Acute Intermittent Porphyria Revenue (2014-2025)
1.5.2 Global Acute Intermittent Porphyria Production (2014-2025)
2 Global Acute Intermittent Porphyria Market Competition by Manufacturers
2.1 Global Acute Intermittent Porphyria Production Market Share by Manufacturers (2014-2019)
2.2 Global Acute Intermittent Porphyria Revenue Share by Manufacturers (2014-2019)
2.3 Global Acute Intermittent Porphyria Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Acute Intermittent Porphyria Production Sites, Area Served, Product Types
2.5 Acute Intermittent Porphyria Market Competitive Situation and Trends
2.5.1 Acute Intermittent Porphyria Market Concentration Rate
2.5.2 Acute Intermittent Porphyria Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Acute Intermittent Porphyria Production Market Share by Regions
3.1 Global Acute Intermittent Porphyria Production Market Share by Regions
3.2 Global Acute Intermittent Porphyria Revenue Market Share by Regions (2014-2019)
3.3 Global Acute Intermittent Porphyria Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Acute Intermittent Porphyria Production
3.4.1 North America Acute Intermittent Porphyria Production Growth Rate (2014-2019)
3.4.2 North America Acute Intermittent Porphyria Production, Revenue, Price ...
| read more...
Related Reports
